NextWave Pharmaceuticals Investors

18 investors on Angel Roster list NextWave Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name NextWave Pharmaceuticals can appear together.

Investors listed
18
With verified email
61%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 18 NextWave Pharmaceuticals investors

The most complete profiles first. Showing 18 of 18.

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • Audrey VallenVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceAd Targeting

    Portfolio: Tynt, CHiL Semiconductor, BelAir Networks, Hyperion Therapeutics and 25 more

    Verified email available

  • David BeierVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Rod FergusonVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceAd Targeting

    Portfolio: Tynt, CHiL Semiconductor, BelAir Networks, Hyperion Therapeutics and 25 more

    Verified email available

  • Andrew JensenVerified

    Venture Capital · United States

    Health CareManufacturingBiotechnologyClinical Trials

    Portfolio: Cybin, TriVascular, Boreal Genomics, NextWave Pharmaceuticals and 5 more

    Verified email available

  • Caley CasteleinVerified

    Venture Capital · United States

    Health CareManufacturingBiotechnologyClinical Trials

    Portfolio: Cybin, TriVascular, Boreal Genomics, NextWave Pharmaceuticals and 5 more

    Verified email available

  • Dayton Misfeldt

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Fred Craves

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Matt Kronmiller

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Scott Braunstein

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Shahan Soghikian

    Venture Capital · United States

    AdvertisingHealth CareE-commerceAd Targeting

    Portfolio: Tynt, CHiL Semiconductor, BelAir Networks, Hyperion Therapeutics and 25 more

    Contact details available

  • Sophie Phillips

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • carl goldfischer

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many NextWave Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 18 NextWave Pharmaceuticals investors. 11 of them (61%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (17) and Private Equity Firms (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do NextWave Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Seed (1).

Where are NextWave Pharmaceuticals investors based?

Most are based in the United States (18).

Which companies have NextWave Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Dermira (13), TRIA Beauty (13), VYNE Therapeutics (13), PowerVision (11) and ViewRay (10).

How do I contact NextWave Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.